Concepedia

Åse Ballangrud

ÅB

Statistics

Publications

39

Citations

3.3K

H-Index

29

Active since

1997

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Ioannina

NewYork–Presbyterian Hospital

University of Alberta

Åse Ballangrud is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation therapy.

ORCID

Publications per year

1997–2023

39

Publications

39

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic, Steven M. Larson, George Sgouros et al. · Blood · 2002 · 467 citations · Full text

, , +14

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

Zachary A. Kohutek, Yoshiya Yamada, Timothy A. Chan et al. · Journal of Neuro-Oncology · 2015 · 301 citations · Full text

, , +13

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

Michael R. McDevitt, E Barendswaard, Dangshe Ma et al. · PubMed · 2000 · 258 citations

, , +17

A Phase 2 Trial of Stereotactic Radiosurgery Boost After Surgical Resection for Brain Metastases

Cameron Brennan, Jonathan T. Yang, Patrick Hilden et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 242 citations · Full text

, , +17

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

George Sgouros, Åse Ballangrud, Joseph G. Jurcic et al. · PubMed · 1999 · 209 citations

, , +17

1–5 of 39